Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma

• Egile Nagusiak: Huang Ao (Egilea), Zhang Xin (Egilea), Zhou Jian (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2021-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract The past years have witnessed the vigorous development of immunotherapy, mainly immune checkpoint inhibitors (ICIs) targeting the programmed cell death-1 (PD-1) protein and its ligand, PD-L1, and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4). Indeed, ICIs have largely revolutionized...